China News Service, December 11, according to a comprehensive report, according to data from Johns Hopkins University in the United States, as of 7:28 on December 11, Beijing time, a total of 69.48 million confirmed new crown cases worldwide and a total of 1.58 million deaths people.
At present, many countries are actively promoting the new crown vaccination plan.
On the 10th, an external panel of experts from the US Food and Drug Administration (FDA) voted overwhelmingly for the emergency use of Pfizer’s vaccine.
In the United Kingdom, the second 81-year-old who received the new crown vaccine was named "William Shakespeare", which caused heated discussions on the Internet.
The picture shows the 81-year-old Shakespeare vaccinated against the new crown.
Image source: Screenshot of the BBC News website.
["Shakespeare" received the new crown vaccine in the UK]
The UK has officially started vaccinating Pfizer's new crown vaccine since December 8. Thousands of people have received injections in British hospitals and clinics.
Coincidentally, the second person in the UK to receive the new crown vaccine was an 81-year-old man from Warwickshire named William Shakespeare, the same name as the famous British poet and playwright Shakespeare.
According to the New York Times, the old man smiled after being vaccinated at Coventry University Hospital in central England and said, "From now on, it will change our lives, won't it?"
But before this, two British National Health Service (NHS) staff experienced allergic reactions after receiving the vaccine.
In this regard, the British regulatory agency said that people with a history of severe allergic reactions should not receive the new crown vaccine.
The British Medicines and Health Products Regulatory Authority said the recommendation applies to people who have responded to drugs, food or vaccines.
Canada is the second country to approve Pfizer’s new crown vaccine after the United Kingdom, and the country’s initial vaccination will begin next week.
Vulnerable groups such as medical staff and the elderly will become the first batch of vaccinators.
Regarding the news of two adverse reactions to British vaccination, Canadian health officials said they would continue to investigate the situation.
Canadian officials have pre-ordered up to 76 million doses of this vaccine.
In addition, three vaccines from AstraZeneca, Modena and Johnson & Johnson are awaiting approval by the government.
In Russia, Günzburg, director of the National Research Center for Epidemiology and Microbiology of Russia "Gamaleya", said on the 10th that more than 150,000 Russians have been vaccinated with the "Satellite V" new crown vaccine.
Russian Defense Minister Shoigu also stated that as of the 9th, more than 8,500 Russian soldiers have been vaccinated against the new crown.
In addition, Brazil, Mexico, France, Germany, Spain, South Korea, Cambodia and other countries have recently announced their new crown vaccination plans.
On December 7, local time, pedestrians on the streets of Manhattan, New York.
Photo by China News Agency reporter Liao Pan
[Pfizer vaccine is supported by FDA expert group]
In the United States, the US Food and Drug Administration (FDA) advisory panel voted in favor of 17 to 4, recommending that the FDA approve the emergency use of the new crown vaccine jointly developed by Pfizer and the German Biotech Company.
One member of the group abstained.
On the 10th local time, a US Food and Drug Administration (FDA) advisory group composed of vaccine experts and infectious disease experts met to review the new crown vaccine jointly developed by Pfizer and the German Biotech Company.
Experts discussed and voted on the vaccine's effectiveness and safety data, and finally a majority voted in favor of recommending the FDA to approve the vaccine for emergency use in people aged 16 and over.
The expert panel also discussed two reports on severe allergic reactions among British vaccinators and discussed a large part of the Pfizer plan.
The documents prepared by the FDA before the meeting did not point out any new safety or effectiveness issues, which made some people optimistic that the United States will soon follow the United Kingdom and Canada authorized vaccines.
FDA Commissioner Hahn said before the meeting that the agency is carefully reviewing all data on Pfizer vaccines, including potential allergic reactions following the British warning.
He said that if it is finally approved, the label of the vaccine will include information about who the vaccine is suitable for and who should not be vaccinated.
According to the "Washington Post", officials in the Trump administration responsible for accelerating vaccine development and delivery said that if as expected, the FDA will quickly pass emergency authorization and the vaccine will be shipped to states within 24 hours.
Officials said that vaccination will begin early next week.